CellWell record HH-101381
Batch-Dependent Safety Signal: Nationwide Analysis of Suspected Adverse Events Following COVID-19 Vaccination in Germany
Vibeke Manniche; Vit Karásek; Max Schmeling; Jonathan D. Gilthorpe; Tomáš Fürst; Peter Riis Hansen
2026
In plain language
Analyzing nationwide German pharmacovigilance data, suspected adverse event rates for Comirnaty, Spikevax, and Vaxzevria were highest in early 2021, with Vaxzevria reaching 620.9 per 1000 doses before falling to 7.4 by weeks 12-16.
- Evidence
- Emerging
- Design
- Preprint
Cite this record: https://thecellwell.org/studies/HH-101381
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.